Laboratory equipment and consumables
The main task of OMB is to ensure the possibility to provide high‑quality medical services
We strive to undertake all issues of equipping with modern instruments and consumables, as well as to organize their supply accurately so that our customers being able to focus on diagnostic problems and treatments of patients exclusively.
Today OMB is all about our team of industry experts
In 2026 OMB turns 35. We’re truly grateful for the open dialogue we’ve built with you over the years — our reliable partners. We're convinced that business, first and foremost, is about relationships between people. Especially in times of change, your voice has guided us and continues to help us choose the right direction.
Today OMB is all about our team of industry experts constantly searching for solutions, so your work can run smoothly — because, at the end of the day, people’s health and well-being depend on it. Our goal is to keep earning your trust, so you can focus your energy where it matters most: treating your patients
CEO
in our portfolio
for supply
Trying to maintain its position in the then market the OMB operated with automobiles and real estate. Our aim was to earn money for developing projects in medicine.
Five people worked for the OMB then.
We also registered some trademarks. Our sales grew. Twenty people worked for the OMB.
The Invitro, a large private lab, was opened, based on an OMB project, a year later.
The OMB was 100 people strong.
Our new project aimed at a better use of the medical lab capacity and informatization of lab processes evolved into a solitary legal entity. We got a partner in Astana: OMB-Kazakhstan.
We are 24 years old and… we are still growing!
We are already 25 years old - anniversary!
On the new site, we have implemented more convenient navigation, added advanced functionality, simplified the search and ordering of goods in the catalog, and made the site available for use on mobile devices.
Now our representatives are also in Saratov, Kaluga and Chelyabinsk.
We rebranded and updated logo of the company. Our company started to create electronic workflow for our customers and organized the first client day. We entered into the new market of innovations for hospitals, signed an exclusive agreement with JVM Company (South Korea). Our company recruited service engineers in Voronezh and Krasnoyarsk. In Moscow office started education activities #self-development with OMB and OMB lecture courses
We got a certificate (ГОСТ Р ИСО 9001-2015) that confirms quality of our company’s procedures and our customer-oriented approach. Our company won first prize for dynamics of sales Point-of-Care instruments of Siemens Healthiness. BioMerieux Company successfully audited our company for compliance with international quality standards of processes
The turnover in the company in 2021 exceeded 5 billion rubles
The company was awarded as “Partner of the year in sales of the private market” by Siemens Healthineers
Our company installed more than 400 instruments and increased the number of signed state contracts about 41% over 2020
We trained medical staff in red zone of hospitals (COVID-19 patients)
We added in our portfolio new products for preanalytical phase, express diagnostics and blood sedimentation rate
The representative office was opened in Ryazan, the service engineer started to work in PermThe turnover in the company in 2021 exceeded 5 billion rubles
The company was awarded as “Partner of the year in sales of the private market” by Siemens Healthineers
Our company installed more than 400 instruments and increased the number of signed state contracts about 41% over 2020
We trained medical staff in red zone of hospitals (COVID-19 patients)
We added in our portfolio new products for preanalytical phase, express diagnostics and blood sedimentation rate
The representative office was opened in Ryazan, the service engineer started to work in Perm
We successfully passed an audit by Roszdravnadzor (the Federal Service for Surveillance in Healthcare) and obtained a new license for the maintenance of medical equipment. This certification validates the quality of our service processes and our compliance with the GOST ISO 13485-2017 quality management system standard for medical devices.
We have launched a partnership with Erba, a renowned international manufacturer of equipment and reagents for in vitro diagnostics, specializing in fields such as biochemistry, hematology, and urinalysis.
According to the employer ratings by hh.ru (a leading Russian recruitment platform), our company has been ranked among the top 150 employers in the category for small companies (100-250 employees) headquartered in Moscow.
Following a successful audit, we have renewed our ISO 9001:2015 certification for our Quality Management System.
We have secured exclusive partnerships with Maccura, Snibe, Dymind, Succeeder, Edan, and Lifotronic—leading manufacturers of laboratory equipment and consumables from China.
We conducted 130 technical training sessions on new products for our service team, which includes our engineers and application specialists. Approximately half of these sessions were delivered in English by representatives from the manufacturing companies.
We have further strengthened our partnerships with leading Chinese manufacturers of medical equipment and consumables, enhancing our portfolio with an exclusive new range of products for immunochemistry, hematology, and hemostasis diagnostics.
Our company has been named one of the Top 200 Best Companies of 2024 by Headhunter (hh.ru). This achievement is a testament to the hard work, dedication, and exceptional talent of every member of our team. This recognition inspires us to continue pushing forward, innovating, and reaching for new heights.
We are digitizing and optimizing our company’s processes to deliver first-class service to our clients.
We have received 17 registration certificates for Succeeder products, including 5 coagulation analyzers along with their reagents and consumables.
At the end of the year, new Maccura CLIA analyzer (the high-throughput chemiluminescent analyzer i6000) and reagents of infectious disease panel (HBsAg, аnti-HCV, аnti-TP, HIV Ag/Ab) were registered
Automation and technological improvements: we have launched an updated client portal and enhanced our technological landscape by implementing the 1C ERP system.
Expanding into new territories: our Sales Management team has grown in the Southern Federal District, with a new company representative in Crimea (Simferopol).
Expanding our pool of logistics partners (April 2025): To optimize transport costs throughout the global supply chain, we have signed contracts with two leading logistics companies (AsstrA LLC and Transimperial LLC). We also plan to involve them in customs clearance for our shipments in the future.
Trying to maintain its position in the then market the OMB operated with automobiles and real estate. Our aim was to earn money for developing projects in medicine.
Five people worked for the OMB then.
We also registered some trademarks. Our sales grew. Twenty people worked for the OMB.
The Invitro, a large private lab, was opened, based on an OMB project, a year later.
The OMB was 100 people strong.
Our new project aimed at a better use of the medical lab capacity and informatization of lab processes evolved into a solitary legal entity. We got a partner in Astana: OMB-Kazakhstan.
We are 24 years old and… we are still growing!
We are already 25 years old - anniversary!
On the new site, we have implemented more convenient navigation, added advanced functionality, simplified the search and ordering of goods in the catalog, and made the site available for use on mobile devices.
Now our representatives are also in Saratov, Kaluga and Chelyabinsk.
We rebranded and updated logo of the company. Our company started to create electronic workflow for our customers and organized the first client day. We entered into the new market of innovations for hospitals, signed an exclusive agreement with JVM Company (South Korea). Our company recruited service engineers in Voronezh and Krasnoyarsk. In Moscow office started education activities #self-development with OMB and OMB lecture courses
We got a certificate (ГОСТ Р ИСО 9001-2015) that confirms quality of our company’s procedures and our customer-oriented approach. Our company won first prize for dynamics of sales Point-of-Care instruments of Siemens Healthiness. BioMerieux Company successfully audited our company for compliance with international quality standards of processes
The turnover in the company in 2021 exceeded 5 billion rubles
The company was awarded as “Partner of the year in sales of the private market” by Siemens Healthineers
Our company installed more than 400 instruments and increased the number of signed state contracts about 41% over 2020
We trained medical staff in red zone of hospitals (COVID-19 patients)
We added in our portfolio new products for preanalytical phase, express diagnostics and blood sedimentation rate
The representative office was opened in Ryazan, the service engineer started to work in PermThe turnover in the company in 2021 exceeded 5 billion rubles
The company was awarded as “Partner of the year in sales of the private market” by Siemens Healthineers
Our company installed more than 400 instruments and increased the number of signed state contracts about 41% over 2020
We trained medical staff in red zone of hospitals (COVID-19 patients)
We added in our portfolio new products for preanalytical phase, express diagnostics and blood sedimentation rate
The representative office was opened in Ryazan, the service engineer started to work in Perm
We successfully passed an audit by Roszdravnadzor (the Federal Service for Surveillance in Healthcare) and obtained a new license for the maintenance of medical equipment. This certification validates the quality of our service processes and our compliance with the GOST ISO 13485-2017 quality management system standard for medical devices.
We have launched a partnership with Erba, a renowned international manufacturer of equipment and reagents for in vitro diagnostics, specializing in fields such as biochemistry, hematology, and urinalysis.
According to the employer ratings by hh.ru (a leading Russian recruitment platform), our company has been ranked among the top 150 employers in the category for small companies (100-250 employees) headquartered in Moscow.
Following a successful audit, we have renewed our ISO 9001:2015 certification for our Quality Management System.
We have secured exclusive partnerships with Maccura, Snibe, Dymind, Succeeder, Edan, and Lifotronic—leading manufacturers of laboratory equipment and consumables from China.
We conducted 130 technical training sessions on new products for our service team, which includes our engineers and application specialists. Approximately half of these sessions were delivered in English by representatives from the manufacturing companies.
We have further strengthened our partnerships with leading Chinese manufacturers of medical equipment and consumables, enhancing our portfolio with an exclusive new range of products for immunochemistry, hematology, and hemostasis diagnostics.
Our company has been named one of the Top 200 Best Companies of 2024 by Headhunter (hh.ru). This achievement is a testament to the hard work, dedication, and exceptional talent of every member of our team. This recognition inspires us to continue pushing forward, innovating, and reaching for new heights.
We are digitizing and optimizing our company’s processes to deliver first-class service to our clients.
We have received 17 registration certificates for Succeeder products, including 5 coagulation analyzers along with their reagents and consumables.
At the end of the year, new Maccura CLIA analyzer (the high-throughput chemiluminescent analyzer i6000) and reagents of infectious disease panel (HBsAg, аnti-HCV, аnti-TP, HIV Ag/Ab) were registered
Automation and technological improvements: we have launched an updated client portal and enhanced our technological landscape by implementing the 1C ERP system.
Expanding into new territories: our Sales Management team has grown in the Southern Federal District, with a new company representative in Crimea (Simferopol).
Expanding our pool of logistics partners (April 2025): To optimize transport costs throughout the global supply chain, we have signed contracts with two leading logistics companies (AsstrA LLC and Transimperial LLC). We also plan to involve them in customs clearance for our shipments in the future.
- Venous blood collection systems
- Capillary blood collection systems
- Urine collection systems
- Bioscience
OF MEDICAL EMERGENCY
OF DIABETES MELLITUS
TICARET ANONIM SIRKETI
Moscow, 125124, Russia
(GMT+3)
(GMT+3)